The effects of probiotic administration on patients with prediabetes: a meta-analysis and systematic review

• Published in: Journal of translational medicine Vol. 20; no. 1; pp. 498 - 13
• Main Authors: Li, Ya, Wu, You, Wu, Lili, Qin, Lingling, Liu, Tonghua
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02.11.2022; BioMed Central; BMC
• Subjects: Bias; Blood Glucose; Care and treatment; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes; Dietary supplements; Glucose; Glycated Hemoglobin; Health aspects; Hemoglobin; High density lipoprotein; Homeostasis; Humans; Insulin; Insulin resistance; Low density lipoprotein; Meta-analysis; Metabolism; Microbiota; Patient outcomes; Placebos; Prediabetes; Prediabetic state; Prediabetic State - drug therapy; Probiotics; Probiotics - pharmacology; Probiotics - therapeutic use; Random control trials; Review; Systematic review; Triglycerides; China; Probiotics; Systematic review; Random control trials; Prediabetes; Meta-analysis
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-022-03695-y

This paper aimed to examine the effects of probiotics on eight factors in the prediabetic population by meta-analysis, namely, fasting blood glucose (FBG), glycated haemoglobin A1c (HbA1c), homeostatic model assessment of insulin resistance (HOMA-IR), quantitative insulin sensitivity check index (QUICKI), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C), and the mechanisms of action are summarized from the existing studies. Seven databases (PubMed, Web of Science, Embase, Cochrane Library, SinoMed, CNKI, and Wanfang Med) were searched until March 2022. Review Manager 5.4 was used for meta-analysis. The data were analysed using weighted mean differences (WMDs) or standardized mean differences (SMDs) under a fixed effect model to observe the efficacy of probiotic supplementation on the included indicators. Seven publications with a total of 460 patients were included. According to the meta-analysis, probiotics were able to significantly decrease the levels of HbA1c (WMD, -0.07; 95% CI -0.11, -0.03; P = 0.001), QUICKI (WMD, 0.01; 95% CI 0.00, 0.02; P = 0.04), TC (SMD, -0.28; 95% CI -0.53, -0.22; P = 0.03), TG (SMD, -0.26; 95% CI -0.52, -0.01; P = 0.04), and LDL-C (WMD, -8.94; 95% CI -14.91, -2.97; P = 0.003) compared to levels in the placebo group. The effects on FBG (WMD, -0.53; 95% CI -2.31, 1.25; P = 0.56), HOMA-IR (WMD, -0.21; 95% CI -0.45, 0.04; P = 0.10), and HDL-C (WMD, 2.05; 95% CI -0.28, 4.38; P = 0.08) were not different from those of the placebo group. The present study clearly indicated that probiotics may fulfil an important role in the regulation of HbA1c, QUICKI, TC, TG and LDL-C in patients with prediabetes. In addition, based on existing studies, we concluded that probiotics may regulate blood glucose homeostasis in a variety of ways. This meta-analysis has been registered at PROSPERO with ID: CRD42022321995.